MXL
Maxlinear, Inc
$74.40
-14.44 (-16.25%)
At close · Jul 16
Market Cap
$6.43B
Shares
89,545,959
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-01 | 2026-05-28 | |
| 8-K | 2026-05-21 | 2026-05-20 | |
| 10-Q | 2026-04-23 | 2026-03-31 | |
| 8-K | 2026-04-23 | 2026-04-22 | |
| DEF 14A | 2026-04-02 | 2026-05-20 | |
| 8-K | 2026-02-17 | 2026-02-13 | |
| 10-K | 2026-01-29 | 2025-12-31 | |
| 8-K | 2026-01-29 | — | |
| 8-K | 2025-11-24 | 2025-11-20 | |
| 10-Q | 2025-10-23 | 2025-09-30 | |
| 8-K | 2025-10-23 | — | |
| 8-K | 2025-07-23 | — | |
| 10-Q | 2025-07-23 | 2025-06-30 | |
| 8-K | 2025-05-21 | 2025-05-20 | |
| 10-Q | 2025-04-23 | 2025-03-31 | |
| 8-K | 2025-04-23 | — | |
| DEF 14A | 2025-04-07 | 2025-05-20 | |
| 8-K | 2025-01-29 | — | |
| 10-K | 2025-01-29 | 2024-12-31 | |
| 8-K | 2024-11-01 | 2024-10-29 | |
| 10-Q | 2024-10-23 | 2024-09-30 | |
| 8-K | 2024-10-23 | — | |
| 8-K | 2024-08-23 | 2024-08-21 | |
| 8-K | 2024-07-24 | — | |
| 10-Q | 2024-07-24 | 2024-06-30 | |
| 8-K | 2024-05-29 | 2024-05-22 | |
| 8-K | 2024-05-24 | 2024-05-23 | |
| 10-Q | 2024-04-24 | 2024-03-31 | |
| 8-K | 2024-04-24 | — | |
| DEF 14A | 2024-04-04 | 2024-05-23 | |
| 8-K | 2024-01-31 | — | |
| 10-K | 2024-01-31 | 2023-12-31 | |
| 8-K | 2024-01-08 | 2024-01-03 | |
| 8-K | 2023-10-25 | — | |
| 10-Q | 2023-10-25 | 2023-09-30 | |
| 10-Q | 2023-07-27 | 2023-06-30 | |
| 8-K | 2023-07-26 | — | |
| 8-K | 2023-07-26 | — | |
| 8-K | 2023-06-28 | — | |
| 8-K | 2023-05-11 | 2023-05-10 | |
| 8-K | 2023-05-09 | — | |
| 8-K | 2023-04-26 | — | |
| 10-Q | 2023-04-26 | 2023-03-31 | |
| DEF 14A | 2023-04-07 | 0001-01-01 | |
| 10-K | 2023-02-01 | 2022-12-31 | |
| 8-K | 2023-02-01 | — | |
| 8-K | 2022-11-17 | 2022-11-14 | |
| 8-K | 2022-10-25 | — | |
| 10-Q | 2022-10-25 | 2022-09-30 | |
| 8-K | 2022-09-09 | — |
Showing 1–50 of 101 filings
Key facts
CIK
1288469
CUSIP
57776J100
13F (30d)
32 filings
32 filers
Visit website
Investor relations